← All blog posts

Sales Enablement for Medical Devices: Showpad vs Highspot vs Specialized Solutions

Showpad and Highspot are strong general B2B platforms — but neither was built for medical device sales, and both are merging into bigger, more general suites. An honest comparison on what MedTech actually needs: compliance, clinical visualization, mobile delivery, CRM, and creative.

Published Feb 16, 2023

If your medical device company has outgrown PowerPoint and Dropbox and started evaluating real sales enablement platforms, two names come up fast: Showpad and Highspot. Both are established, both are capable, and either is a real step up from a shared drive.

There is a third option: a MedTech sales enablement platform built only for medical device companies.

The question worth asking before you sign with either: can a platform built for general B2B sales actually carry the way medical devices get sold?

It's also worth knowing the ground is moving under both. Showpad merged with Bigtincan in late 2025. Highspot has announced plans to merge with Seismic. The two biggest names in the category are folding into even bigger, even more general suites — the opposite direction from where a MedTech sales team needs to go.

Here's an honest look at both, and a third option built for a different job.

Showpad: Strong Platform, Built for Everyone

Founded in Belgium in 2011, Showpad pairs content management with sales coaching. For medical device teams, a couple of things genuinely stand out. Its 3D and augmented-reality module lets a prospect experience a device virtually — useful for demonstrations that are hard to stage in person. Its personalized video messaging helps reps stay in front of physicians between visits. And its mobile app is a real strength for field sellers, with reliable offline access.

What it isn't is built for healthcare. There are no native compliance workflows, no clinical-specific content structure, and limited design customization is a common complaint. And the creative work — turning your clinical story into something worth presenting — isn't included. On Showpad, custom content and design are a separate, often five-figure, line item.

As of late 2025, Showpad is part of Bigtincan under Vector Capital, with packaging and pricing still settling.

Highspot: Solid Content Management, Coaching-Focused

Founded in Seattle in 2012, Highspot's strength is content management paired with training and coaching. Its content recommendations adapt to user roles, which helps organizations running several sales motions at once. Its AI assistant, Highspot Copilot, drafts emails, summarizes calls, and surfaces next-best content.

The core limitation is the same as Showpad's: Highspot was built for general enterprise B2B, not MedTech. Clinical visualization and creative production lean on your own team or third-party partners rather than living inside the platform. And Highspot has announced plans to merge with Seismic — another step toward a bigger, more general suite.

Neither company publishes pricing. Both are quote-based, per-seat enterprise contracts running into the tens of thousands a year, with implementation and onboarding commonly adding five figures more before your team sends a single presentation.

Nuvue vs Showpad vs Highspot: What Actually Matters in MedTech

 ShowpadHighspotNuvue
Built forGeneral B2BGeneral B2BMedical devices only
Who owns it nowMerged with Bigtincan, Vector CapitalMerging into Seismic, keeping the Seismic nameIndependent
Content libraryYesYes, Spots and SmartPagesYes
Content organised by sales stageYesYesYes, MedTech stages
PlaybooksYesYes, Sales PlaysYes
Rep coaching and role-playYesYes, and it is their strongest suitNo
Presentations built in the systemNo, files are uploadedNo, files are uploadedYes
Brand control on the content itselfPermissions on filesPermissions on filesBuilt into the content
Buyer-facing spaceShared SpacesDigital sales roomsThe presentation, or a gated portal
Customer portals after the saleNoNoBranded training portals, included
Built-in CRMNo, integrates with yoursNo, integrates with yoursYes
Who builds the contentYour teamYour teamNuvue's creative team
Pricing publishedNoNoYes

Last verified: September 2026. Showpad and Highspot are compared from their own published documentation.

Feature lists blur together. Here's where the three genuinely diverge on the things that decide a medical device sale.

Who it's built for. Showpad and Highspot are general B2B platforms — their customers span manufacturing, consumer goods, and enterprise tech. “Built for everyone” means built for no one in particular, and MedTech-specific needs get handled through configuration. Nuvue is built only for medical device companies.

Software vs. managed service. Showpad and Highspot sell you a license and a login — implementation, content strategy, and keeping the library current are your team's job. Nuvue is a managed service with an in-house creative studio. We interview your leadership, build your clinical story into the system, train your reps, and keep building. The creative work the others charge extra for is the work we do.

CRM and content — together or apart. Showpad and Highspot are enablement layers that sit on top of a separate CRM; you still run HubSpot or Salesforce alongside them. Nuvue merges CRM and content management into one system, so what your reps present and where each deal stands live in the same place.

The recipient's experience. Both incumbents have strong rep-side mobile apps. The real difference is what lands on the doctor's phone. Nuvue delivers every asset — a one-sheet or a 30-page presentation — as a responsive link, not a file, so it displays perfectly on whatever device the prospect opens it on.

Before and after the sale. The incumbents focus on pre-sale enablement and internal rep training. Nuvue carries the whole cycle — including post-sale customer education that keeps the practice engaged and tracks that engagement after the deal closes.

Cost and setup. Neither incumbent publishes pricing; both are per-seat contracts with seat minimums and mid-term penalties as you add reps. Nuvue is transparent: a flat $2,950 to onboard, then monthly licensing based on team size — a model that doesn't punish you for growing.

The Honest Verdict

For a general B2B company, Showpad and Highspot are strong, and either beats a shared Dropbox folder. If your only goal is organizing content and getting basic analytics, you'll be fine with either.

But in MedTech, the things these platforms treat as edge cases — locked compliance language, clinical visualization, mobile delivery to physicians, a CRM that actually knows what was presented — are the entire job. The moment you're configuring a general platform to do medical device work, that's not a setup phase. That's the difference between a general content tool and a system built for healthcare selling, and it shows up fast.

What Nuvue Was Built To Be

Nuvue was built for one industry: medical devices. Not a general platform with a healthcare setting switched on.

That means brand-locked presentations reps assemble but can't alter, so your compliance language and clinical claims stay intact in the field. Content that lives in one place and updates globally — when a claim changes, every rep's version changes with it, usually inside 24–48 hours, because our team handles it. Mobile-responsive assets delivered as links, not files. Engagement analytics tied to the content, and a CRM in the same system, so leadership can see what's actually moving deals. And customer education that keeps working after the sale.

It isn't a tool you run. It's a sales system we run with you — across a cycle that can take a year, and well past the close.

The Questions That Should Drive Your Decision

Whatever you evaluate, these are the questions worth asking:

Does every asset render perfectly on a phone, delivered as a link instead of a downloaded file?

Can marketing lock clinical claims and approved language while reps still assemble what they need?

Are engagement analytics tied to specific content — and connected to your pipeline?

Does content update globally, so every shared link is current?

Has the vendor actually done medical device sales — or will you be teaching them?

If the honest answer to most of those is “no, but we could configure it,” the platform was built for someone else.

See how Nuvue compares for your team. Book a 30-minute demo.

Frequently asked

Questions readers also ask.

Q: How do Showpad and Highspot compare for medical device sales teams?

Both are established enterprise enablement platforms with strong content management and analytics. Showpad leans toward buyer-facing content experience, AR/3D, and field mobile; Highspot leans toward content management with training and coaching. Neither was designed for the compliance, clinical, and field realities of medical device sales — both are general B2B platforms you configure to fit.

Q: What limitations do general sales enablement platforms have for MedTech companies?

They're built for broad B2B, so MedTech needs — locked regulatory language, clinical visualization, procedure-specific paths, mobile delivery to physicians — come through configuration and paid services, not out of the box. That takes time, expertise, and ongoing upkeep. And the creative work of building the actual content usually isn't included.

Q: What should medical device companies look for in a specialized platform?

Native modular presentation building, locked compliance language reps can't alter, mobile-responsive delivery as links rather than files, engagement analytics tied to specific content, and ideally a CRM in the same system. In MedTech these are table stakes — not add-ons you unlock with custom configuration.

Q: Is a specialized MedTech platform worth it over a general one?

Once you add up the rep hours lost hunting for content, the compliance risk of outdated materials in the field, the separate creative budget, and the per-seat costs that grow with your team, the math usually favors purpose-built. General platforms look cheaper until you total the configuration, services, and workarounds.

Q: Can small and mid-sized MedTech companies benefit from a specialized platform?

Often they benefit most — they don't have the sales-ops headcount to run a general platform or the in-house creative team to feed it. A managed service built for medical device sales lets a lean team punch above its weight, and the right model scales with growth instead of penalizing it.

Get demo

End the chaos. See how MedTech sells.

A 30-minute walkthrough, tailored to your product and your sales cycle.